AI assistant
Sending…
Cartesian Therapeutics, Inc. — Director's Dealing 2020
Jan 21, 2020
33483_dirs_2020-01-21_ec38d68f-ee94-46b7-9b38-2769e6262d9a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2020-01-16
Reporting Person: Johnston Lloyd P. (COO and SVP, R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-16 | Common Stock | M | 5128 | $0.47 | Acquired | 16734 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-01-16 | Employee Stock Option (right to buy) | $0.47 | M | 5128 | Disposed | 2020-01-19 | Common Stock (5128.0) | Direct |
Footnotes
F1: All shares underlying this option are fully vested.
More from Cartesian Therapeutics, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Mar 30
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Jan 9
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8